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ABSTRACT
We evaluated the DMFT (decayed, missing and fi lled teeth) index and the prevalence of candidia-
sis, linear gingival erythema, oral hairy leukoplakia, herpes simplex, aphthous ulcers, Kaposi’s sar-
coma and lymphoma, as well as the association with TCD4 count, viral load (VL) and antiretroviral 
therapy (ART) in 140 HIV-infected adult individuals. A standardized examination to determine the 
DMFT index and the presence of oral lesions was conducted. Demographic data, TCD4 count and 
use of ART were obtained from medical records. A high number of decayed teeth detected among 
patients undergoing ART resulted in a mean DMFT of 16.9 teeth. It was observed that 24.2% of the 
individuals had at least one oral lesion. Candidiasis was the most frequent lesion and was associated 
with the TCD4 count. Oral hairy leukoplakia was associated with an increased VL. Regular use of 
ART was inversely associated with the occurrence of lesions. Overall, the studied population showed 
low prevalence of oral lesions and high DMFT index. The use of ART seems to reduce the occurrence 
of these lesions. Higher TCD4 count and a lower VL were associated with an improved oral health 
status in HIV+ individuals. 
Keywords: oral mucosal lesions, DMFT index, tooth decay, HIV infection.
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INTRODUCTION
Between 1980 and 2007, 474,237 cases of ac-
quired immunodefi ciency syndrome (AIDS) 
were notifi ed in Brazil, with the Southeast 
region being the one presenting the highest 
number of cases (289,074). The Northern re-
gion had 16,103 cases, with 1,862 in the state 
of Rondônia. Additionally, during a similar pe-
riod of time (1980 – 2006), 192,709 deaths due 
to AIDS were notifi ed in Brazil, with 549 in the 
state of Rondônia.1 
The initial infection by the human immu-
nodefi ciency virus (HIV) is accompanied by 
unspecifi c symptoms, such as fever and ma-
laise. Subsequently, the lymphadenopathy pro-
ceeds to a chronic and asymptomatic phase, as 
viral replication is, partially controlled by the 
immune system. Duration of this stage var-
ies to factors such as viral phenotype, host’s 
immune response, and use of antiretroviral 
therapy (ART). If it is not controlled by medi-
cation, viral replication continues and other 
symptoms, such as diarrhea, weight loss and oral 
candidiasis, appear and full-blown AIDS is es-
tablished, which consists of a large number of 
acquired or reactivated diseases due to immu-
nosuppression. Opportunistic diseases caused 
by viruses, bacteria, protozoa, and fungi and, 
together with some related neoplasias,2 indi-
cate a severely immunocompromised state.3 
Around 1% of HIV-infected individuals, 
so called non-progressors, can maintain nor-
mal TCD4 lymphocyte levels and low viral 
load (VL) for periods as long as 10 to 20 years.4 
Specifi cally, in the oral environment the lesions 
associated with HIV infection include candi-
diasis, herpes simplex, oral hairy leukoplakia 
(OHL), cytomegalovirus (CMV) infection, 
varicella-zoster virus infection, papilloma vi-
rus infection, linear gingival erythema (LGE), 
gingivitis and necrotizing ulcerative periodon-
titis, Kaposi’s sarcoma, and aphthous ulcers, 
which are acknowledged as important markers 
of AIDS clinical stages.5-9
Tooth decay is an infectious disease that 
affects all populations worldwide. In HIV-
infected children, as the degree of immuno-
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suppression increases, so does the incidence of caries.10,11 
Phelan et al.12 observed a higher incidence of caries and a 
lower number of teeth present in the oral cavity of HIV-in-
fected adult women. However, in Brazil, the DMFT data in 
HIV-infected populations are scarce. Awareness of the mag-
nitude of this problem in Brazil may allow for comparison 
with other countries and might highlight the need to imple-
ment or intensify preventive programs aimed at this group 
of individuals and at professionals working in this area. Such 
actions could guarantee a better quality of life through ad-
equate care for the ones in need. 
The treatment of the HIV infection/AIDS aims at lim-
iting viral replication and, consequently, preventing and 
controlling opportunistic infections. To monitor disease 
progression, TCD4 cell count and VL13 must be monitored 
throughout treatment. TCD4 counts < 200 cells/mm3 indi-
cate higher probability of developing opportunistic infec-
tions, whereas VL > 50,000 to 100,000 copies/mL can result 
in a rapidly compromised immune system.3 In Brazil, ART 
is recommended for all symptomatic individuals infected 
by HIV, and asymptomatic individuals with a TCD4 count 
< 350 cells/mm3.3,14
Therefore, the objective of the present cross-sectional 
study was to assess the DMFT index in association with oral 
mucosal lesions HIV-infected individuals living in the city 
of Porto Velho, state of Rondônia, Brazil. Moreover, a pos-
sible association between the oral health status and TCD4 
count, VL quantifi cation, and ART use was investigated. 
METHODS
Sample calculation
Of 970 medical records of individuals registered at the Refer-
ence Outpatient Service (ROS), receiving care at Policlínica 
Municipal Dr. Rafael Vaz e Silva, a sample of 130 partici-
pants was chosen, to provide a power of 80% and an α error 
of 0.05. For the sample calculation, we considered the mean 
prevalence observed in the literature of oral candidiasis, lin-
ear gingival erythema, oral hairy leukoplakia, aphthous ul-
cers, Kaposi’s sarcoma, herpes simplex and lymphoma. 
Inclusion and exclusion criteria 
The convenience sample consisted of patients that came to 
Policlínica for medical, dental or psychological care, or to 
collect ART medication during the period of August 2007 
to January 2008. HIV-infected men and women, aged 18 
years or older, registered and followed at the ROS were 
evaluated. Only individuals that agreed to participate in 
the study and signed the Free and Informed Consent Form 
were kept in the study (protocol of approval by the Eth-
ics Committee in Research #121/07). Former smokers who 
had quit smoking less than three years before enrollment, 
and individuals that did not follow the outpatient clinic 
treatment were excluded. 
Data collection 
Participants underwent an oral assessment by a single ex-
aminer at the dental office of the clinic, under artificial 
light, according to the appropriate biosafety guidelines 
and with the help of a clinical dental mirror #5 (Duflex, 
SS White, Rio de Janeiro, RJ, Brazil), a dental probe #5 
(Duflex, SS White, Rio de Janeiro, RJ, Brazil), a blunt-
tip probe (Duflex, SS White, Rio de Janeiro, RJ, Brasil), a 
wooden spatula and sterilized gauze pads.
The examiner was trained to identify the following 
oral mucosal lesions: candidiasis (erythematous, pseudo-
membranous and angular cheilitis), linear gingival ery-
thema, oral hairy leukoplakia, aphthous ulcers, herpes 
simplex, Kaposi’s sarcoma and lymphoma, which were 
photographed (Sony DSC-H2, San Diego, CA, USA). 
Following a standardized oral exam, a single examiner 
assessed all present teeth, except for the third molars, 
in order to determine the DMFT (decayed, missing and 
filled teeth) index, according to the criteria established 
by the World Health Organization (WHO).15 Each tooth 
was classified as Decayed: D (decayed teeth and filled 
teeth with caries or temporary filling material), Missing 
– subdivided in two categories; Extracted: E (teeth lost 
due to caries or other reasons) or Extraction indicated: Ei 
(extensive tooth decay that prevented tooth restoration 
procedures), or Filled: F (teeth that had been filled with 
permanent filling material and with no caries). Accord-
ing to the Brazilian Ministry of Health,16 an examiner is 
adequately trained when his intra-examiner index reach-
es a reproducibility rate of 97.5%. The information on 
age, gender, laboratory data, smoking habit, and time of 
ART use were collected from medical records. TCD4 lym-
phocyte counts and VL quantifications obtained up to 
three months before or after the oral clinical assessment 
were considered in the study, as the VL tends to stabilize 
with the beginning of the humoral response.17 
As the use of ART depends on symptomatology and the 
TCD4 cell count,14 patients that had used ART regularly for 
at least twelve months were considered users. All data were 
entered in a form especially created for the present study. 
Participants were advised on the importance of follow-
up and regular use of the antiretroviral therapy, as well as 
the importance of oral hygiene. Those who presented with 
oral mucosal lesions received adequate treatment. Those 
who needed dental treatment were scheduled to receive it. 
Only cases that needed endodontic treatment and/or pros-
thesis were referred to the Dental Clinic of Faculdade São 
Lucas and the Dental Specialization Centers – DSCs.
Statistical analysis 
Data were stored in Excel™ spreadsheets and the indi-
vidual was considered the analysis unit. The statistical 
analysis was carried out with BioEstat 4.0 and SPSS 16.2 
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software, and the level of significance was set at 5% 
(p < 0.05). The normality of data was initially evaluated 
by Kolmogorov-Smirnov test (Lilliefors Test).
The Chi-square test was used for the comparative 
analyses regarding the occurrence of oral mucosal le-
sions, as well as their presence according to smoking 
status. The Mann-Whitney test was used for the intra-
group analysis of the association between these lesions 
and TCD4 counts, VL quantification and use of ART, 
whereas ANOVA was used to verify the differences be-
tween the number of decayed teeth and TCD4 counts, 
VL quantification and use of ART. 
The individual DMFT was obtained by adding the 
teeth included in any of criteria (D, E, Ei or F) and 
the mean DMFT was obtained by calculating the sim-
ple arithmetic mean of the DMFT index of all partici-
pants. 
RESULTS 
To reach a sample size of 140 eligible participants (39 ± 
10.7 years), 238 individuals were invited to participate. 
Two participants were excluded as they did not meet the 
age criterion. A high number of subjects refused to par-
ticipate (96) due to the need to undergo the intra-oral 
clinical assessment. 
The study sample consisted of 66 men (40.8 ± 11.5 
years), 74 women (37.5 ± 9.8 years); 37 were smokers. 
There were 2.9% participants in the age-range between 
14 and 19 years, 15% between 20 and 29 years, 37.9% 
between 30 and 39 years, 25.0% between 40 and 49 years, 
and 19.2% were older than 50 years. 
The mean TCD4 count was of 380 cells/mm3. Of the 
140 participants, 58% had intermediate counts of TCD4 
(between 200-500 cells/mm3), 23% presented more than 
500 cells/mm3, 14% presented 50-200 cells/mm3 and 
only 5% had fewer than 50 lymphocytes/ mm3.
Regarding ART use, 68% of the individuals reported 
using a combination of three antiretroviral drugs for a 
mean time of 45.4 months (± 37.5 months).
Fifty-three percent of individuals had undetectable 
HIV VL, 23% had < 10,000 copies/mL, 16% had between 
10,000 and 100,000 copies/mL, and only 8% of the par-
ticipants had more than 100,000 copies/mL. 
Out of the total, 75.8% (106/140) disclosed no oral 
mucosal lesion. In the remaining 34 patients only one 
oral lesion was present in 82.4% (28/34). whereas 14,7% 
(5/34) had two lesions, and only one patient (2.9%) had 
simultaneously three different lesions (linear gingival 
erythema, candidiasis and aphthous ulcer). The most 
frequently identified oral mucosal lesion was candidiasis 
(20 patients) (Figure 1), with erythematous candidiasis 
being observed in 16 cases, followed by angular cheilitis 
in three cases, and pseudomembranous candidiasis in 
two patients. There were no cases of Kaposi’s sarcoma 
or lymphoma. Additionally, aphthous ulcers was present 
in six patients, herpes simplex in one, and oral hairy leu-
koplakia in five patients. Smoking, reported by 37 par-
ticipants, was not associated with the occurrence of oral 
mucosal lesions (p = 0.99). 
Figure 1: Oral lesion types. Different small letters between parenthesis indicate significant statistical difference 
(Chi-square test, p < 0.05) between the occurrence of lesions.
Oral mucosal lesion occurrence 
22% (b)
49% (a)
15% (b/c)
2% (c)
12% (b/c)
 Linear gingiva Candidiasis Aphthous Herpes Oral hairy
 erythema  ulcer simplex leukoplakia
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The presence of lesions was inversely proportional to the 
TCD4 count, i.e., the higher the number of cells, the lower 
the occurrence of lesions (Figure 2). As for the VL, as its lev-
els increased, so did the occurrence of lesions. 
There was a trend towards the association of an increas-
ing number of oral mucosal lesions and being without ART, 
albeit without statistical signifi cance. 
Among the 64 individuals who had an undetect-
able VL, 96.8% (62) was on regular use of ART, and 
82.8% (53) had a TCD4 count > 200 cells/mm3. Only 
Table 1. Presence of oral lesions according to TCD4 count, viral load (VL) and use of ART
Oral lesions Candidiasis  Linear gingival  Herpes simplex Oral hairy leukoplakia Aphthous ulcers
  n (%) erythema n (%) n (%) n (%) n (%) 
 > 500 0(b) (0.0%) 1(a) (3.4%) 0(a) (0.0%) 0(a) (0.0%) 0(a) (0.0%)
 200 to 500 14(a)(19.7%) 4(a) (5.9%) 1(a) (1.4%) 1(a) (1.4%) 5(a) (7.0%)
TCD4+
 50 to 200 3(a/b) (17.6%) 2(a) (11.8%) 0(a) (0.0%) 1(a) (5.9%) 0(a) (0.0%)
 < 50 2(a) (25.0%) 1(a) (16.7%) 0(a) (0.0%) 2(a) (25.0%) 0(a) (0.0%)
Viral
 Undetectable 11(a) (17.2%) 4(a) (6.3%) 1(a) (1.6%) 0(b) (0.0%) 3(a) (4.7%)
load < 10,000 3
(a) (10.7%) 3(a) (10.7%) 0(a) (0.0%) 0(b/c) (0.0%) 1(a) (3.6%)
VL 10,000 to 100,000 2
(a) (10.5%) 1(a) (5.3%) 0(a) (0.0%) 1(a/b) (5.3%) 0(a) (0.0%)
 > 100,000 3(a) (33.3%) 0(a) (0.0%) 0(a) (0.0%) 3(a) (33.3%) 0(a) (0.0%)
ART
 + (68%) 15(a) (15.8%) 7(a) (7.4%) 1(a) (1.1%) 0(a) (0.0%) 3(a) (3.2%)
 - (32%) 5(a) (11.1%) 2(a) (4.4%) 0(a) (0.0%) 5(b) (11.1%) 3(a) (6.7%) 
Different small letters in the same column indicate significant statistical difference (p < 0.05) between the subgroups of TCD4, 
viral load and ART use.
+, user; -, non-user.
one patient with undetectable VL had TCD4 count 
< 50 cells/mm3.
The group with TCD4 count > 500 cells/mm3 showed 
a lower prevalence of candidiasis, when compared to 
the group with TCD4 count between 200-500 cells/mm3 
(p = 0.0238) and to the group with TCD4 count < 50 
cells/mm3 (p = 0.0254). Oral hairy leukoplakia was more 
prevalent among patients with VL > 100,000 copies/mL 
than among those with undetectable VL and with < 10,000 
copies/mL (p < 0.05). These data are shown in Table 1.
Figure 2: Percentage of individuals with a positive diagnosis for at least one of the oral mucosal lesions, evaluated 
comparatively to those that did not exhibit any lesions at the moment of the intra-oral assessment. * Statistically significant 
difference at the intra-group analysis (p < 0.05; Mann-Whitney).
Presence of oral mucosal lesions in relation to TCD4 count (A) and viral load (B)
lesion no lesion lesion no lesionA B
96.6%
*
3.4%
26.8%
73.2%
* 64.7%
*
66.7%
15.2%
84.8%
*
60.7%
*
39.3%33.3%
*
35.3%
> 500 200 to 500 50 to 200 < 50 Up to 10,000   More than 10,000
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Figure 3 shows the means of decayed – D, extracted – E, 
extraction indicated – Ei and fi lled teeth – F (restored), as 
well as the general mean DMFT index. There was no sta-
tistically signifi cant difference when the DMFT index was 
correlated with TCD4 cell counts (ANOVA), or when each 
Figure 3: Mean DMFT Index: D, decayed; Missing: E, extracted; Ei, extraction indicated; F, filled (restored).
Table 2. Association between the DMFT index and the use of ART 
  Decayed (D) Extracted (E) Extraction indicated (Ei) Filled (F) DMFT
  n (Mean) n (Mean)  n (Mean)  n (Mean)  n (Mean) 
ART
 + (n = 95) 120 (1.3)(a) 1094 (11.6)(a) 79 (0.8)(a) 343 (3.6)(a) 1636(17.4)(a) 
 - (n = 45) 123 (2.7)(b) 454 (9.9)(a) 37 (0.8)(a) 117 (2.5)(a) 731 (15.9)(a)
Different small letters in the same column indicate significant statistical difference (p < 0.05) between the participants who 
were users (+) or non-users (-) of ART.
DISCUSSION
In the state of Rondônia, Amazonian region, Brazil, there 
are only six healthcare centers providing specialized care 
for patients with HIV/AIDS, and two of them are located 
in the capital city, Porto Velho. Of these, only ROS offers 
dental care, which was the setting of the present study. 
The main objective of the present study was to determine 
the DMFT index and the prevalence of oral mucosal le-
sions in HIV-infected patients and its association with 
TCD4 count, viral load (VL) quantification, and antiret-
roviral therapy (ART) use. 
criterion (D, E, Ei and F) were compared among the indi-
viduals with different VL counts (ANOVA).
However, higher number of decayed teeth – D was ob-
served among patients who were not on ART (p = 0.004; 
t-Test) (ANOVA) (Table 2).
These data represents important information on which 
to base the planning of more effective actions to copy with 
the studied health problem. The results of the present study 
confi rmed two trends of the AIDS epidemics: the aging of 
the infected population due to higher survival rates9,18,19 and 
the feminization.20,21
Availability of ART at the Brazilian Public Healthcare Sys-
tem (SUS) was established by Federal Law # 9313, of December 
1996, and guaranteed the broad and free distribution of ART to 
the Brazilian population.22 According to Hammer et al.,23 com-
bination ART therapy is more effi cient than monotherapy, as it 
results in an increase in TCD4 count and concomitant decrease 
1.7
11.1
0.8
3.3
16.9
D E Ei F DMFT
DMFT Index
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in VL, which, in turn, results in a decrease in the rate of oral mu-
cosal lesions.24-26 This low prevalence of lesions was confi rmed 
by the present study. Moreover, the combination therapy has 
shown to be effective in improving/restoring the quality of life 
and increasing survival rates of infected patients.27 
The type of candidiasis most frequently observed was the 
erythematous type, in accordance with Noce et al.,9 but in 
disagreement with other authors, such as Souza et al.,11 Mat-
tos, Santos and Ferreira,28 Ranganathan and Hemelatha,29 
and Ranganathan et al.,30 who reported that pseudomebra-
nous candidiasis was the most common type. These authors 
also mentioned the presence of angular cheilitis as a frequent 
fungal infection, a manifestation also observed in this study, 
albeit with a low incidence (2%). 
Linear gingival erythema represented 6% of the cases, a 
value that was similar to that of several studies involving Bra-
zilian populations7,17,28,31 (Fabro et al.7 – 2%; Grando et al.17 
– 5.9%; Mattos, Santos and Ferreira28 – 4.3%; and Ferreira et 
al.31 – 2.5%).
Aphthous ulcers represented 4% of the cases in the present 
study. The literature presents an assorted prevalence of these 
alterations. Ulcers are reported by studies carried out in Brazil 
as ranging from 0.9%32 up to 23.5%,5 with most of studies 
showing a prevalence of approximately 3%. 
Oral hairy leukoplakia (OHL) has also been reported 
with prevalences varying from 2.1% through 6%.9,11,17,30,33 
It is noteworthy that several authors described OHL as a mark-
er of HIV infection progression.13,34,35 Thus, the relatively low 
frequency of this lesion in the population of the present study 
suggests an indicator of HIV control as a result of combina-
tion ART. Patton et al.36 reported that HIV-infected patients 
who present OHL only among those with VL > 20,000 copies/
mL, regardless of the TCD4 count. In contrast, there were fi ve 
patients with OHL identifi ed in the present study.
Kaposi’s Sarcoma and lymphoma were not seen in this study. 
According to Girotto et al.,37 the decrease in the prevalence of 
these lesions is associated with the use of combination ART. In 
Porto Velho, since the ROS started treating patients, there have 
never been any report of lymphoma in the oral cavity. 
Candiani et al.38 reported a signifi cant decrease in oppor-
tunistic infections, hospitalizations and death in HIV-infected 
patients following the introduction of highly-active antiret-
roviral therapy (HAART), a combination of three antiretro-
viral drugs. Birnbaum et al.,24 Greenwood, Zakrzewska and 
Robinson,26 Ferreira et al.,31 and Coogan, Greenspan and 
Challacombe39 reported changes in the prevalence of oral 
mucosal lesions following the introduction of ART, including 
the reduction of the incidence of candidiasis, OHL and KS. 
A low prevalence of KS was also associated with the use of 
ART, as reported by Greenspan et al.25 In the present study, 
68% of the patients used combination ART for a mean pe-
riod of 45 months (SD: 37.5 months). In approximately 20% 
(95) of the patients on regular use of ART, some type of oral 
mucosal lesion was identifi ed, whereas in the group with-
out ART therapy, approximately 31% (45) presented lesions. 
Greenspan et al.40 reported that after the start of HAART ther-
apy, a signifi cant decrease in the quantifi cation of VL occurs, 
as well as an increase in TCD4 count. The results obtained in 
the present study show a decrease in the prevalence of lesions 
in the oral mucosa among those on HAART, thus suggesting 
that, in fact, the combined HAART maintains or restores the 
immune response and, additionally, decreases the VL, result-
ing in a better quality of life and longer survival rates.
According to Mattos, Santos and Ferreira,28 most of the 
patients with oral mucosal lesions had TCD4 counts be-
tween 200 and 399 cells/mm3, whereas in patients with VL 
up to 10,000 copies/mL fewer lesions were identifi ed. Birn-
baum et al.24 and Patton et al.36 showed that the increase in 
VL is also characterized by the increase in the prevalence of 
lesions in the oral mucosa. 
Similarly, in the present study, patients with VL values 
> 10,000 copies/mL had higher prevalence of lesions. 
Miziara, Lima and Cortina35 demonstrated that patients with 
candidiasis or OHL had lower TCD4 lymphocyte counts 
and higher VL values, when compared to patients that did 
not express these manifestations clinically. A study carried 
out by Ferreira et al.31 demonstrated a higher prevalence of 
lesions in the oral mucosal lesions in patients with TCD4 
count < 200 cells/mm3 and a higher prevalence of these le-
sions in patients with high VL values. In agreement, in the 
present study, the increase in the TCD4 count was associated 
with the decrease in the occurrence of oral mucosal lesions. 
In Brazil, few studies have reported their experience on den-
tal caries and HIV infection, and most of them were carried out 
with HIV-infected children.10,12,32,41 The differences between the 
prevalence and the incidence of caries in individuals with and 
without HIV infection have yet to be elucidated. However, by rec-
ognizing that dental caries is an infectious disease, and knowing 
that several side effects of ART therapy can contribute to an inad-
equate oral hygiene, as well as to an inappropriate diet, the HIV 
infection seems to function as a risk factor for caries. 
Bretz et al.41 observed a high prevalence of caries (mean 
of 42.9 surfaces) in an HIV-infected population from Hou-
ston, Texas. A study carried out by Phelan et al.12 showed a 
comparison of prevalence of caries between the HIV-infected 
and uninfected women. These authors observed higher rate 
of coronal and radicular caries, in addition to a lower number 
of permanent teeth in the oral cavity of HIV-infected women, 
concluding that the occurrence of caries was higher in indi-
viduals with decreased TCD4 count. In Brazil, Silveira and 
Rangel32 observed a high prevalence of caries with a mean 
DMFT = 23 (D = 12; E = 7.5; Ei =1.5; F = 2) in 123 adult 
patients of both sexes.
In agreement with other studies, this study also showed 
a high prevalence of caries. The mean DMFT index of the 
participants was of 16.9; the number of decayed teeth and 
DMFT index and oral mucosal lesions associated with HIV infection
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teeth with extraction indicated was low (1.7 and 0.8, respec-
tively) and the number of extracted teeth was high (11.1). It 
can be observed that these numbers are far from the targets 
proposed by the WHO for the year 2010, such as: the pres-
ence of 20 or more teeth in the oral cavity for 96% of the in-
dividuals at the age range of 35 to 44 years and no lost teeth 
at the age of 18 years.42 In the present study, at the age range 
of 35 to 44 years, 49 individuals were assessed. Of these, 23 
individuals (47%) had fewer than 20 teeth in the oral cavity, 
that is, less than half of the target number proposed by the 
WHO; there were only two participants who were 18 years 
old, and both had at least two missing teeth. 
The SB Brazil epidemiological surveillance, carried out 
by the Ministry of Health in 2002, indicated that, at the age 
range 35 to 44 years, the mean of missing teeth was of 14.77 
for the Northern region, whereas in the present study, the 
mean was of 12.12 for HIV-infected individuals. Regarding 
the decayed and fi lled teeth criteria, the results demonstrat-
ed better oral health status for HIV-infected patients (D = 
1.41; F = 4.0), when compared to the general population of 
the Northern region (D = 2,97; F = 1.89).43 Therefore, the 
comparison of these data suggest a better access to dental 
care services for the studied population, confi rming the im-
portance of the surgeon-dentist in reference services provid-
ing care for HIV/AIDS patients. 
The results from the present study reﬂ ect the importance 
of adequate care given to HIV/AIDS patients, as the correct 
management provides a better quality of life to the patient, 
which was demonstrated here through the low prevalence of 
oral mucosal lesions. It should also be pointed out the impor-
tance of creating/implementing oral rehabilitation programs 
(dental prosthesis), considering the large number of missing 
teeth, as well as the creation of more reference centers with 
multiprofessional teams, so that a new effective management 
and follow-up of HIV-infected patients can be accomplished. 
CONCLUSIONS
The studied population, which consisted primarily of indi-
viduals with intermediate TCD4 counts and undetectable 
VL, showed low prevalence of oral mucosal lesions and a 
high DMFT index, with the high number of extracted teeth 
contributing the most for this high index. 
The most frequently observed lesion was candidiasis, 
which was related to TCD4 count, whereas the increase in the 
VL was associated with the occurrence of OHL. The DMFT 
index was not associated with VL, TCD4 count or ART use. 
Only the criterion Decayed tooth, when analyzed separately, 
was higher in the group that was not on ART use. 
Individuals with higher counts of TCD4 lymphocytes 
and lower counts of VL tended to present fewer oral mucosal 
lesions associated with HIV infection. Additionally, the use 
of antiretroviral therapy showed an association with lower 
prevalence of lesions, especially OHL. 
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